Alphatec Holdings logo
Alphatec Holdings ATEC
$ 11.58 4.94%

Annual report 2025
added 02-24-2026

report update icon

Alphatec Holdings Balance Sheet 2011-2026 | ATEC

Annual Balance Sheet Alphatec Holdings

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

347 M 442 M 295 M 270 M 143 M -68.8 M 6.82 M 16.5 M 18.6 M 26.6 M 69.4 M 62.9 M 33.6 M 19.4 M 7.53 M

Long Term Debt

501 M 575 M 511 M 350 M 326 M 38 M 53.4 M 42.3 M 37.8 M 43.1 M 480 K 74.6 M 50 M 40 M 23.8 M

Long Term Debt Current

6.3 M 6.45 M 5.16 M 4.84 M 4.21 M 885 K 1.31 M 3.28 M 3.31 M 3.11 M 80.1 M 8.08 M 4.92 M 1.7 M 4.4 M

Total Non Current Liabilities

- - - - - - 89.9 M 81.3 M 81.6 M 95.6 M 57.9 M 132 M 114 M 79.5 M 64.2 M

Total Current Liabilities

219 M 153 M 158 M 139 M 101 M 58.3 M 36.4 M 30.6 M 29.7 M 40.1 M 125 M 63.6 M 79.7 M 56.8 M 57.1 M

Total Liabilities

- - - - - - 126 M 112 M 111 M 136 M 183 M 196 M 194 M 136 M 121 M

Deferred Revenue

10.4 M 10.5 M 13.9 M 12 M 15.3 M - - - - - 648 K 1.3 M 1.01 M 1.36 M 4.51 M

Retained Earnings

-1.42 B -1.28 B -1.12 B -932 M -781 M -638 M -559 M -502 M -459 M -457 M -427 M -249 M -236 M -153 M -138 M

Total Assets

791 M 776 M 805 M 521 M 572 M 261 M 170 M 129 M 84.7 M 94.2 M 147 M 345 M 366 M 382 M 367 M

Cash and Cash Equivalents

161 M 139 M 221 M 84.7 M 187 M 108 M 47.1 M 29.1 M 22.5 M 19.6 M 11.2 M 19.7 M 21.3 M 22.2 M 20.7 M

Book Value

791 M 776 M 805 M 521 M 572 M 261 M 43.6 M 17.6 M -26.7 M -41.5 M -36.6 M 149 M 172 M 246 M 245 M

Total Shareholders Equity

12.4 M -14.2 M 78.1 M -34.7 M 80.7 M 130 M 43.6 M 17.6 M -26.7 M -41.5 M -36.6 M 149 M 172 M 246 M 245 M

All numbers in USD currency

Quarterly Balance Sheet Alphatec Holdings

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

552 M 546 M 575 M 526 M 517 M 512 M 511 M 507 M 455 M 419 M 350 M 348 M - 327 M 326 M 321 M 55.8 M 38.6 M 38 M 38 M 38 M 38 M 53.4 M 53.4 M 53.4 M 53.4 M 42.3 M 42.3 M 42.3 M 42.3 M 37.8 M 37.8 M 37.8 M 37.8 M 43.1 M 43.1 M 43.1 M 43.1 M 480 K 480 K 480 K 480 K 74.6 M 74.6 M 74.6 M 74.6 M 50 M 50 M 50 M 50 M 40 M 36 M 35.3 M 40 M 23.8 M 23.8 M 23.8 M 23.8 M

Deferred Revenue

11.5 M 11.3 M 10.5 M 11.6 M 11.8 M 13.6 M 13.9 M 13.8 M 13.9 M 13.9 M 12 M 12.3 M - 14.9 M 15.3 M 16.7 M 20.4 M - - - - - - - - - - - - - - - - - - - 799 K 736 K 648 K 831 K 1 M 648 K 1.3 M 1.3 M 1.3 M 1.3 M 1.01 M 1.01 M 1.01 M 1.01 M 1.36 M 1.36 M 1.36 M 1.36 M 2.77 M 2.77 M 2.77 M 2.77 M

Retained Earnings

-1.37 B -1.33 B -1.28 B -1.25 B -1.21 B -1.17 B -1.12 B -1.07 B -1.03 B -976 M -932 M -898 M -861 M -824 M -782 M -742 M -699 M -661 M -638 M -638 M -638 M -638 M -559 M -559 M -559 M -559 M -502 M -502 M -502 M -502 M -459 M -459 M -459 M -459 M -457 M -457 M -457 M -457 M -427 M -427 M -427 M -427 M -249 M -249 M -249 M -249 M -236 M -236 M -236 M -236 M -153 M -153 M -153 M -153 M -138 M -138 M -138 M -138 M

Total Assets

790 M 785 M 776 M 746 M 769 M 775 M 805 M 670 M 628 M 570 M 521 M 516 M - 549 M 572 M 598 M 441 M 405 M 261 M 261 M 261 M 261 M 170 M 170 M 170 M 170 M 129 M 129 M 129 M 129 M 84.7 M 84.7 M 84.7 M 84.7 M 94.2 M 94.2 M 94.2 M 94.2 M 146 M 146 M 146 M 146 M 345 M 345 M 345 M 345 M 366 M 366 M 366 M 366 M 382 M 382 M 382 M 382 M 367 M 367 M 367 M 367 M

Cash and Cash Equivalents

157 M 153 M 139 M 81 M 99.8 M 144 M 221 M 123 M 101 M 117 M 84.7 M 106 M 107 M 152 M 187 M 224 M 76.6 M 191 M 108 M 15.7 M 108 M 108 M 47.1 M 47.1 M 47.1 M 47.1 M 29.1 M 29.1 M 29.1 M 29.1 M 22.5 M 22.5 M 22.5 M 22.5 M 19.6 M 19.6 M 9.32 M 7.76 M 11.2 M 10.5 M 8.9 M 11.2 M 19.7 M 19.7 M 19.7 M 19.7 M 21.3 M 21.3 M 21.3 M 21.3 M 22.2 M 22.2 M 22.2 M 22.2 M 20.7 M 20.7 M 20.7 M 20.7 M

Book Value

790 M 785 M 776 M 746 M 769 M 775 M 805 M 670 M 628 M 570 M 521 M 516 M - 549 M 572 M 598 M 441 M 405 M 261 M 261 M 261 M 261 M 170 M 170 M 170 M 170 M 129 M 129 M 129 M 129 M 84.7 M 84.7 M 84.7 M 84.7 M 94.2 M 94.2 M 94.2 M 94.2 M 146 M 146 M 146 M 146 M 345 M 345 M 345 M 345 M 366 M 366 M 366 M 366 M 382 M 382 M 382 M 382 M 367 M 367 M 367 M 367 M

Total Shareholders Equity

23.8 M -85.9 M -14.2 M -1.36 M 17.1 M 37.6 M 78.1 M -44.2 M -28.2 M -58.4 M -34.7 M -20.9 M 12.1 M 43.4 M 79.4 M 112 M 214 M 108 M 130 M 130 M 130 M 130 M 43.6 M 43.6 M 43.6 M 43.6 M 17.6 M 17.6 M 17.6 M 17.6 M -26.7 M -26.7 M -26.7 M -26.7 M -41.5 M -41.5 M -41.5 M -41.5 M -36.6 M -36.6 M -36.6 M -36.6 M 149 M 149 M 149 M 149 M 172 M 172 M 172 M 172 M 246 M 238 M 246 M 246 M 245 M 245 M 245 M 245 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of Alphatec Holdings, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
AxoGen AxoGen
AXGN
$ 32.95 6.32 % $ 1.52 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 12.25 2.6 % $ 1.66 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 9.41 3.75 % $ 266 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 38.07 3.82 % $ 5.67 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.6 0.11 % $ 122 M usaUSA
Electromed Electromed
ELMD
$ 24.44 2.78 % $ 207 M usaUSA
Globus Medical Globus Medical
GMED
$ 92.86 3.13 % $ 12.6 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.46 1.68 % $ 130 M franceFrance
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.85 1.09 % $ 1.12 M usaUSA
Align Technology Align Technology
ALGN
$ 179.74 7.71 % $ 13.5 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.87 5.79 % $ 760 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.05 1.94 % $ 17.8 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 87.04 2.22 % $ 3.02 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 16.28 3.3 % $ 382 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 65.02 2.33 % $ 3.55 B britainBritain
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
LENSAR LENSAR
LNSR
$ 5.69 1.07 % $ 68 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 87.74 1.49 % $ 113 B usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.11 1.23 % $ 870 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Myomo Myomo
MYO
$ 0.68 0.44 % $ 28.5 M usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.63 3.5 % $ 39.2 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.79 1.19 % $ 351 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 62.82 1.57 % $ 93 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 36.55 5.73 % $ 1.13 B usaUSA